Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05538338 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Platelet Rich Plasma for Insufficient Endometrium

Study acronym: PIER
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Oct 2025 to Oct 2026
    • Study completion date: Dec 2025 to Dec 2027
    v7
  2. Site contact updatedv6
  3. Re-verified, no change to tracked fieldsv5
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Oct 2022 to Oct 15, 2022
    • Site details revised
    v4
  5. Eligibility criteria expanded, about 4 wordsv3
  6. Study title shortened, about 4 wordsv2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To determine the effectiveness of an intrauterine PRP infusion on endometrial thickness and in vitro fertilization (IVF) outcomes in a population of infertile women with a history of unresponsive thin endometrium.
Trial Details
NCT Number NCT05538338
Lead Sponsor Reproductive Medicine Associates of New Jersey
Conditions
(from sponsor)		 Infertility of Uterine Origin
Enrollment 62 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov